TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
AKTS

Aktis Oncology, Inc.

Healthcare · Biotechnology

19.40$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Aktis Oncology, Inc. (AKTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 558 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AKTS
Line item Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q3 24 Q4 24 Q3 25 Q4 25 Q1 26 Q2 26
132 158 149 127 112 103 337 326 279 265 577 558
60 68 60 39 26 29 315 301 249 230 544 525
47 53 43 26 13 15 225 37 180 38 372 82
47 53 43 26 13 15 312 297 246 227 538 517
3.2 4.2 4.8 3.9 6.1 5.6 7.0 – – – 2.2 2.3
5.8 7.6 7.5 6.2 5.5 5.1 3.2 – – – – –
8.1 15 15 15 15 6.5 6.5 – – – – –
8.3 16 15 15 14 13 12 – – – – –
53 57 63 59 58 61 414 414 411 411 71 73
8.8 12 18 16 14 18 17 19 27 31 28 32
0.5 0.8 0.9 0.9 1.0 2.2 1.5 1.3 1.4 1.3 1.4 1.5
2.6 3.1 4.0 6.0 3.2 4.8 0.7 1.9 2.4 1.7 1.2 2.5
79 100 86 68 54 42 -77 -88 -132 -146 506 485
-237 -253 -270 -291 -306 -330 -81 -93 -141 -157 -175 -199
58 68 72 72 73 91 154 53 53 53 55 55

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?